Shenzhen Neptunus Bioengineering Co., Ltd.
|
32.3 Billion CNY
|
97.128%
|
Anhui Fengyuan Pharmaceutical Co., Ltd.
|
4.39 Billion CNY
|
78.873%
|
Dong-E-E-Jiao Co.,Ltd.
|
13.3 Billion CNY
|
93.028%
|
Livzon Pharmaceutical Group Inc.
|
25.04 Billion CNY
|
96.296%
|
Hainan Haiyao Co., Ltd.
|
7.36 Billion CNY
|
87.406%
|
Tus-Pharmaceutical Group Co., Ltd.
|
1.15 Billion CNY
|
19.405%
|
Jilin Aodong Pharmaceutical Group Co., Ltd.
|
32.26 Billion CNY
|
97.125%
|
Changchun High-Tech Industries (Group) Inc.
|
30.74 Billion CNY
|
96.982%
|
Apeloa Pharmaceutical Co.,Ltd
|
12.76 Billion CNY
|
92.734%
|
PKU HealthCare Corp.,Ltd.
|
2.43 Billion CNY
|
61.951%
|
Chengdu Huasun Technology Group Inc., Ltd.
|
2.13 Billion CNY
|
56.515%
|
Dezhan Healthcare Company Limited
|
5.37 Billion CNY
|
82.751%
|
Jinling Pharmaceutical Company Limited
|
4.55 Billion CNY
|
79.612%
|
Jiuzhitang Co., Ltd.
|
5.32 Billion CNY
|
82.593%
|
Huapont Life Sciences Co., Ltd.
|
30.72 Billion CNY
|
96.981%
|
Zhejiang Jingxin Pharmaceutical Co., Ltd.
|
7.98 Billion CNY
|
88.384%
|
Shandong Wohua Pharmaceutical Co., Ltd.
|
1.14 Billion CNY
|
18.954%
|
Hengkang Medical Group Co., Ltd.
|
6.08 Billion CNY
|
84.742%
|
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
|
6.45 Billion CNY
|
85.635%
|
Qianjiang Yongan Pharmaceutical Co., Ltd.
|
2.34 Billion CNY
|
60.473%
|
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
|
19.2 Billion CNY
|
95.169%
|
Jinhe Biotechnology CO., LTD.
|
5.45 Billion CNY
|
82.989%
|
Teyi Pharmaceutical Group Co.,Ltd
|
2.51 Billion CNY
|
63.077%
|
Kunming Longjin Pharmaceutical Co., Ltd.
|
631.63 Million CNY
|
-46.88%
|
Beijing Aosaikang Pharmaceutical Co., Ltd.
|
3.52 Billion CNY
|
73.673%
|
Chengdu Kanghong Pharmaceutical Group Co., Ltd
|
8.52 Billion CNY
|
89.123%
|
Anhui Huangshan Capsule Co., Ltd.
|
1.1 Billion CNY
|
15.896%
|
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
|
2.12 Billion CNY
|
56.342%
|
Zhuhai Rundu Pharmaceutical Co., Ltd.
|
2.22 Billion CNY
|
58.356%
|
Huaren Pharmaceutical Co., Ltd.
|
5.16 Billion CNY
|
82.04%
|
Tianjin Ringpu Bio-Technology Co.,Ltd.
|
6.59 Billion CNY
|
85.935%
|
Shanxi Zhendong Pharmaceutical Co.,Ltd
|
6.18 Billion CNY
|
84.989%
|
Fuan Pharmaceutical (Group) Co., Ltd.
|
5.97 Billion CNY
|
84.475%
|
Hybio Pharmaceutical Co., Ltd.
|
3.27 Billion CNY
|
71.691%
|
Baotou Dongbao Bio-Tech Co.,Ltd
|
2.74 Billion CNY
|
66.166%
|
Hunan Er-Kang Pharmaceutical Co., Ltd
|
5.47 Billion CNY
|
83.067%
|
Changjiang Pharmaceutical Group Co., Ltd.
|
3.44 Billion CNY
|
73.076%
|
Zhejiang Garden Bio-chemical High-tech Co., Ltd.
|
5.26 Billion CNY
|
82.364%
|
Fujian Cosunter Pharmaceutical Co., Ltd.
|
1.61 Billion CNY
|
42.536%
|
Beijing Science Sun Pharmaceutical Co., Ltd.
|
3.62 Billion CNY
|
74.387%
|
Zhejiang Xinguang Pharmaceutical Co., Ltd.
|
930.4 Million CNY
|
0.286%
|
Hainan Poly Pharm. Co., Ltd
|
6.28 Billion CNY
|
85.243%
|
Jiangxi Synergy Pharmaceutical Co., Ltd.
|
3.22 Billion CNY
|
71.201%
|
Wuhan Hiteck Biological Pharma Co.,Ltd
|
2.97 Billion CNY
|
68.776%
|
Shandong Xinhua Pharmaceutical Company Limited
|
8.35 Billion CNY
|
88.895%
|
Zhejiang Tianyu Pharmaceutical Co., Ltd.
|
6.33 Billion CNY
|
85.362%
|
PharmaBlock Sciences (Nanjing), Inc.
|
5.1 Billion CNY
|
81.823%
|
Jinghua Pharmaceutical Group Co., Ltd.
|
3.18 Billion CNY
|
70.872%
|
Zhejiang Hisoar Pharmaceutical Co., Ltd.
|
7.52 Billion CNY
|
87.663%
|
Betta Pharmaceuticals Co., Ltd.
|
9.14 Billion CNY
|
89.857%
|
Shenzhen Kangtai Biological Products Co., Ltd.
|
15.08 Billion CNY
|
93.85%
|
Shandong Shanda Wit Science and Technology Co., Ltd.
|
5.19 Billion CNY
|
82.153%
|
Pacific Shuanglin Bio-pharmacy Co., LTD
|
8.63 Billion CNY
|
89.25%
|
Zhejiang AngLiKang Pharmaceutical CO.,LTD.
|
3.01 Billion CNY
|
69.28%
|
Xiamen Kingdomway Group Company
|
5.35 Billion CNY
|
82.67%
|
ShanXi C&Y Pharmaceutical Group Co., Ltd.
|
1.43 Billion CNY
|
35.262%
|
Walvax Biotechnology Co., Ltd.
|
15.58 Billion CNY
|
94.049%
|
Sunflower Pharmaceutical Group Co.,Ltd
|
6.88 Billion CNY
|
86.519%
|
Harbin Gloria Pharmaceuticals Co., Ltd
|
3.15 Billion CNY
|
70.571%
|
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
|
40.14 Billion CNY
|
97.689%
|
Hunan Hansen Pharmaceutical Co., Ltd.
|
2.33 Billion CNY
|
60.293%
|
Changzhou Qianhong Biopharma CO.,LTD
|
2.76 Billion CNY
|
66.46%
|
Shenzhen Weiguang Biological Products Co., Ltd.
|
2.87 Billion CNY
|
67.751%
|
Honz Pharmaceutical Co., Ltd.
|
2.16 Billion CNY
|
57.16%
|
Northeast Pharmaceutical Group Co., Ltd.
|
15.27 Billion CNY
|
93.926%
|
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
|
4.52 Billion CNY
|
79.476%
|
Guizhou Xinbang Pharmaceutical Co., Ltd.
|
9.24 Billion CNY
|
89.965%
|
Tianjin Lisheng Pharmaceutical Co.,Ltd.
|
5.78 Billion CNY
|
83.951%
|
Zhejiang Yatai Pharmaceutical Co., Ltd.
|
1.42 Billion CNY
|
35.094%
|
Zhejiang NHU Company Ltd.
|
39.15 Billion CNY
|
97.631%
|
ApicHope Pharmaceutical Co., Ltd
|
4.4 Billion CNY
|
78.94%
|
Shanghai Kaibao Pharmaceutical CO.,Ltd
|
4.57 Billion CNY
|
79.742%
|
Beijing SL Pharmaceutical Co., Ltd.
|
6.27 Billion CNY
|
85.222%
|
Yunnan Baiyao Group Co.,Ltd
|
53.78 Billion CNY
|
98.275%
|
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD
|
1.33 Billion CNY
|
30.592%
|
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
|
1.54 Billion CNY
|
39.863%
|
Guangdong Lifestrong Pharmacy Co., Ltd.
|
855.53 Million CNY
|
-8.44%
|
Huadong Medicine Co., Ltd
|
33.5 Billion CNY
|
97.231%
|
Jiangsu Nhwa Pharmaceutical Co., LTD
|
7.32 Billion CNY
|
87.34%
|
Harbin Medisan Pharmaceutical Co., Ltd.
|
3.44 Billion CNY
|
73.054%
|
LanZhou Foci Pharmaceutical Co.,Ltd.
|
2.52 Billion CNY
|
63.303%
|
Tianjin Chase Sun Pharmaceutical Co.,Ltd
|
11.83 Billion CNY
|
92.161%
|
Beijing Beilu Pharmaceutical Co., Ltd
|
2.81 Billion CNY
|
67.095%
|
Nanjing Hicin Pharmaceutical Co., Ltd.
|
1.41 Billion CNY
|
34.615%
|
Renhe Pharmacy Co., Ltd.
|
7.44 Billion CNY
|
87.538%
|
Chongqing Pharscin Pharmaceutical Co., Ltd.
|
1.85 Billion CNY
|
49.891%
|
Zhejiang Xianju Pharmaceutical Co.,Ltd.
|
6.99 Billion CNY
|
86.733%
|
Luoxin Pharmaceuticals Group Stock Co., Ltd.
|
5.11 Billion CNY
|
81.871%
|
Guizhou Bailing Group Pharmaceutical Co., Ltd.
|
7.34 Billion CNY
|
87.376%
|